Certainly, our findings indicate that SP100-AS1/miR-622/ATG3 axis contributes to radioresistance and autophagic flux in CRC, suggesting that it could be a potential target for improving CRC response to radiation therapy. This evidence concerns the gene ATG3 and colorectal carcinoma.